Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis (Q44509013)

3 December 2017

title

Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis (English)

1 reference

3 December 2017

0 references

1 reference

Kadota J

1

1 reference

3 December 2017

Mukae H

2

1 reference

3 December 2017

Ishii H

3

1 reference

3 December 2017

Nagata T

4

1 reference

3 December 2017

Kaida H

5

1 reference

3 December 2017

Tomono K

6

1 reference

3 December 2017

Kohno S

7

1 reference

3 December 2017

publication date

1 July 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

97

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

844-850

1 reference

Diffuse panbronchiolitis. A disease of the transitional zone of the lung

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis preceding ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse Peribronchiolitis Observed in an Italian

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis: efficacy of low-dose erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis in a Hispanic man with travel history to Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Recurrence of diffuse panbronchiolitis after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Therapeutic possibilities for diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis and cystic fibrosis: East meets West

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Interleukin 1 beta, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900042-8

7 January 2021

10.1016/S0954-6111(03)00042-8

Identifiers

DOI

1 reference

3 December 2017

1 reference